MedPage Today: Study shows promise for oral SERD in breast cancer

January 5, 2022

Dr. Virginia Kaklamani, Medicine/Hematology-Oncology and Mays Cancer Center, is the moderator of the discussion presented in this article. The experts comment on two clinical trials of selective estrogen receptor degraders (SERDs) for treatment of metastatic breast cancer. Results of both trials were presented at the San Antonio Breast Cancer Symposium. Read story



Cancer Today: A closer look at survivorship among Hispanics

December 22, 2021

Dr. Amelie Ramirez, Population Health Sciences, Mays Cancer Center and Institute for Health Promotion Research, is quoted in this article that mentions the National Cancer Institute study she is leading. The study aims to recruit 3,000 Hispanic and Latino Americans to understand cancer-related risk and outcomes among this population. Read story




KSAT 12: UT Health San Antonio oncologist answers viewer questions in light of breast cancer symposium

December 13, 2021

Dr. Virginia Kaklamani, breast oncologist at the Mays Cancer Center for patient care services within the UT Health San Antonio MD Anderson Cancer Center, answered viewer questions live on KSAT 12’s Q&A segment. She discussed different aspects of breast cancer including screening guidelines, research being done and the latest advancements for patients diagnosed with breast […]